Hologic Inc.: NovaSure V5 Global Endometrial Ablation Device Approved for Use in Canada and Europe

Hologic Inc. (Nasdaq: HOLX), a global leader in women's health, has announced approval of the NovaSure V5 global endometrial ablation (GEA) device in Canada and Europe. This innovative new version incorporates

Related Keywords

United States ,Canada ,Dennis Riedl ,Hologic Novasure ,Jane Mazur ,Bryan Simon ,Jan Verstreken ,Philippey Laberge ,Hologic Global Women Health Index ,International At Hologic ,Health Equality ,Hologic Inc ,Nasdaq ,Elsevier ,Endometrial Ablation Device Approved ,Business Wire ,Group President ,Hologic Global Women ,Health Index ,Project Health Equality ,Pelvic Anatomy ,Verification Results ,Investor Relations ,Hologic ,Ovasure ,Lobal ,Endometrial ,Tablation ,Device ,Approved ,Europe ,